載入...
BUPRENORPHINE-NALXONE THERAPY IN PAIN MANAGEMENT
Buprenorphine-naloxone (bup/nal in 4:1 ratio; Suboxone®, Reckitt Benckiser Pharmaceuticals Incorporation, Richmond, VA) is approved by the Food and Drug Administration for outpatient office-based addiction treatment. In the past few years, bup/nal has been increasingly prescribed off-label for chron...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3999180/ https://ncbi.nlm.nih.gov/pubmed/24509068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/ALN.0000000000000170 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|